Filing summary
Entity and period: The supplied filing is IKONICS Corporation’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2012. This does not match the request metadata identifying TERAWULF INC.; verify that this is the intended filing before relying on the figures.
Financial performance
- Third quarter: Net sales were $4.23 million, down 3.0% from $4.36 million. Gross profit was $1.75 million (41.4% margin), versus $1.68 million (38.5%). Operating income increased to $338,405 from $296,246, and net income rose to $228,112 from $214,677. Basic and diluted EPS were $0.11, unchanged year over year.
- Nine months: Net sales were $12.79 million, up 1.5%. Gross profit increased to $5.06 million from $5.00 million, while gross margin edged down to 39.6% from 39.7%. Operating income declined to $606,704 from $768,344; net income fell to $408,789 from $561,565. EPS was $0.21 versus $0.28.
- Cash flow: Nine-month operating cash flow was $566,939, compared with $465,752. Investing used $214,892, including $372,217 of property and equipment purchases; financing provided $30,123. Cash increased $382,170 to $2.25 million.
- Liquidity and debt: September 30 cash was $2.25 million and short-term investments were $1.65 million, consisting of fully insured certificates of deposit. Current assets were $9.05 million and current liabilities $1.01 million. No line-of-credit borrowings were outstanding. A $1.25 million credit line was renewed through October 30, 2013, secured by receivables and inventory.
Changes, outlook, and risks
- Quarterly export sales declined 14.1%, partly offset by 9.1% growth in IKONICS Imaging. Management attributed export weakness to Europe and Latin America; domestic sales were approximately flat.
- For the first nine months, domestic sales growth and improved DTX sales partly offset weaker exports and lower Micro-Machining sales. Micro-Machining was affected by a purchasing delay at a major aerospace customer and a nonrecurring 2011 contract. Other-segment gross margin fell to 41.5% from 61.0%, reflecting lower higher-margin Micro-Machining sales and a lower-margin DTX printer sale.
- Inventory increased $340,484, primarily from raw-material purchases for volume discounts and to protect against anticipated price increases. Receivables rose $87,129, which management linked to slightly slower collections.
- Management expected approximately $575,000 of 2012 capital expenditures, funded from cash on hand and operating cash flow, and expected the remainder-of-year effective tax rate to be similar to the first-nine-month rate of 33.6%.
- Management described progress in Micro-Machining and DTX, including aerospace feasibility work and DTX market development, while noting potential effects from Department of Defense budget sequestration, customer demand, competition, raw-material costs, and international-market conditions. Research and development spending rose to $470,165 from $366,940; the period included a $22,324 patent-application abandonment loss.
- The company moved to a self-funded medical plan in January 2012 and reported a $42,000 related liability at quarter-end, with stop-loss insurance. It reported no legal proceedings, off-balance-sheet arrangements, or material control changes; disclosure controls were considered effective.
Important facts to verify
- Confirm the issuer: the filing names IKONICS Corporation, not TERAWULF INC.
- Review the full filing and audited 2011 Form 10-K for accounting policies, segment detail, and risk disclosures; interim results may not indicate full-year performance.
- Monitor export demand and the timing and scale of Micro-Machining and DTX customer orders, including potential defense-budget effects.
- Assess whether elevated inventory converts to sales and whether slower collections affect working capital.
- Verify renewal terms and availability of the $1.25 million credit line, and track planned capital spending and the effective tax rate.